Tesamorelin

Tesamorelin – Premium Research Peptide

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids. This research peptide is structurally modified with a trans-3-hexenoic acid group attached to the tyrosine residue, which enhances its stability and biological activity compared to native GHRH. Tesamorelin selectively binds to GHRH receptors, making it a valuable compound for endocrine and metabolic pathway research.

This product is intended for laboratory and research purposes only. Research Use Only.

Research Applications

Tesamorelin has been extensively studied in peer-reviewed research for its role in growth hormone pathway signaling. The peptide provides researchers with a tool for investigating:

• Growth hormone releasing hormone (GHRH) receptor binding and activation
• Pituitary signaling cascades and downstream effects
• IGF-1 pathway modulation in experimental models
• Lipid metabolism and metabolic pathway research
• Hypothalamic-pituitary axis function studies

Published research indicates Tesamorelin may stimulate growth hormone secretion in a pulsatile manner similar to endogenous GHRH, while maintaining selectivity for GHRH receptors. Studies suggest the peptide’s modified structure provides enhanced resistance to enzymatic degradation, supporting its use in extended research protocols.

Technical Specifications

• Sequence: Modified 44-amino acid GHRH analog
• CAS Number: 218949-48-5
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Molecular Weight: 5,135.9 g/mol
• Purity: ?99%
• Form: Lyophilized powder
• Storage: Store at -20°C, protected from light